Metacognition in Neurological Injury
Longitudinal Examination of Metacognition in Neurological Samples
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of this study is to investigate the trajectory of metacognitive functioning throughout phases of recovery from neurological insult, and to determine its relationship to rehabilitation compliance and functional outcome. It is hypothesized that metacognitive accuracy improves over time, and is a significant predictor of engagement in rehabilitation activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2018
CompletedFirst Posted
Study publicly available on registry
November 26, 2018
CompletedStudy Start
First participant enrolled
December 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedSeptember 1, 2026
August 1, 2026
4.3 years
September 25, 2018
August 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline metamemory performance to completion of rehabilitation
The computerized metamemory test produces scores that are used to calculate a gamma coefficient, which is a quantitative measure of the individual's metacognitive performance/accuracy.
At baseline and at end of length of stay in rehabilitative setting (on average 3 months)
Secondary Outcomes (1)
Change in rehabilitative engagement
At baseline and at end of length of stay in rehabilitative setting (on average 3 months)
Study Arms (2)
Neurological injury
Paper and pencil/computerized assessments of cognitive functioning and metacognitive performance will be administered.
Healthy control
Paper and pencil/computerized assessments of cognitive functioning and metacognitive performance will be administered.
Interventions
Paper and pencil/computerized tests of metacognition
Eligibility Criteria
participants in rehabilitation facility and community-dwelling individuals
You may qualify if:
- history of brain and/or spinal cord injury
- no history of brain or neurological injury/insult (for healthy control group)
- fluent in spoken and written English
- adequate gross motor abilities to provide a button push on a keyboard
You may not qualify if:
- current/past history of psychiatric illness
- learning disorder
- developmental disorder
- diagnosis of Attention Deficit Disorder/Attention Deficit Hyperactive Disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nebraska Lincolnlead
- Quality Living, Inc.collaborator
Study Sites (1)
University of Nebraska-Lincoln
Lincoln, Nebraska, 68588-0308, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathy Chiou, Ph.D.
University of Nebraska Lincoln
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2018
First Posted
November 26, 2018
Study Start
December 13, 2018
Primary Completion
March 30, 2023
Study Completion
March 30, 2023
Last Updated
September 1, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share